PURE BIOSCIENCE, INC. Quarterly Net Cash Provided by (Used in) Financing Activities in USD from Q3 2010 to Q3 2023
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
-
Summary
-
Pure Bioscience, Inc. annual/quarterly Net Cash Provided by (Used in) Financing Activities history and growth rate from Q3 2010 to Q3 2023.
- Pure Bioscience, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending October 31, 2023 was $785K.
- Pure Bioscience, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2024 was $1.79M, a 75.9% increase from 2023.
- Pure Bioscience, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $1.02M, a 71% decline from 2022.
- Pure Bioscience, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $3.5M, a 1364% increase from 2021.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Growth (%)